- Lens Technology announced its full-year net income as 3.02 billion yuan, which shows an increase of 23% year over year, though it didn’t meet the estimated figure of 3.09 billion yuan.
- The company’s revenue reached 54.5 billion yuan, up 17% year over year, surpassing the estimate of 51.86 billion yuan.
- R&D expenses were at 2.32 billion yuan, just under the estimated 2.64 billion yuan based on 2 estimates.
- Gross margin was recorded at 16.6%. This is slightly below the estimated 19.6%.
- A final dividend of 30 RMB cents will be provided per share.
- There are 10 buys, 1 hold and 0 sell ratings currently for Lens Technology.
- All comparisons to past results are derived from values that the company originally disclosed.
A look at Lens Technology Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 4 | |
| Dividend | 4 | |
| Growth | 3 | |
| Resilience | 3 | |
| Momentum | 5 | |
| OVERALL SMART SCORE | 3.8 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Lens Technology Co., Ltd. is positioned for a favorable long-term outlook based on the Smartkarma Smart Scores. With solid ratings in value and dividend factors at 4, the company demonstrates strong financial health and potential for returns to investors. Moreover, Lens Technology’s momentum score of 5 indicates a positive market sentiment and the company’s ability to capitalize on current trends for growth.
While the growth and resilience scores are slightly lower at 3, Lens Technology’s diverse product line, which includes optical lenses, electronic components, and metal parts, reflects a level of stability and adaptability in the market. Overall, the combination of high momentum and strong value and dividend scores suggests a promising future for Lens Technology as it continues to innovate and meet market demands.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
